Company / Income Tax per Share
United Therapeutics Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$8.46
FY2025
5-year range
$2.65 / $8.46
FY2021-FY2025
Trend
+15.7%
vs FY2024
Sector context
#2 of 201
Health Care
What the data says
Among 201 Health Care companies, United Therapeutics is in the bottom 1% for income tax per share. Income Tax per Share has increased for 4 consecutive years, from $2.65 in FY2021 to $8.46 in FY2025.
Based on SEC 10-K filings.
8.46 in FY2025 with a 5-year CAGR of +24.5%. Ranks 2nd among 201 companies in Health Care.
Increased from $6.29 to $8.46 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +19.6%
- 5-Year CAGR
- +24.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 201This company $8.46 Sector average $1.35
▼
+527.5% above sector average
Key checks
Key Insights
- United Therapeutics's income tax per share has grown for 4 consecutive years.
- In FY2025, income tax per share increased 15.7% year-over-year.
- Ranks #2 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.46 | +15.7% |
| FY2024 | $7.31 | +16.2% |
| FY2023 | $6.29 | +27.0% |
| FY2022 | $4.95 | +86.6% |
| FY2021 | $2.65 | -6.2% |
| FY2020 | $2.83 | +303.7% |
| FY2019 | -$1.39 | -135.4% |
| FY2018 | $3.92 | -57.1% |
| FY2017 | $9.14 | +20.7% |
| FY2016 | $7.57 | -9.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026